Genomics

Dataset Information

High glucose associated YTHDC1 lactaylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy


ABSTRACT: High glucose associated YTHDC1 lactaylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy

PROVIDER: PRJNA1234198 | ENA |

REPOSITORIES: ENA